Taken together, our findings show that in 50 out of 61 OSN-APS (81.9%) at least one aPL/cofactor antibody was detected using the assays under test; in particular, 50 out of 61 patients (82%) were positive for at least one of the tests used. This evidence concerns the gene FASLG and autoimmune polyendocrinopathy.